Tracking a new Treatment's Real-World impact on rare swelling disorder

NCT ID NCT07001280

Summary

This study follows 200 patients with hereditary angioedema (HAE) for four years after they start a medication called garadacimab. The main goal is to see how well the drug reduces painful swelling attacks and improves patients' daily lives outside of controlled clinical trials. Researchers will track attack frequency, side effects, and quality of life to understand the treatment's real-world benefits and safety.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEREDITARY ANGIOEDEMAS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Charité - Campus Charité Mitte

    RECRUITING

    Berlin, 10117, Germany

    Contact Email: •••••@•••••

  • HZRM Haemophilie-Zentrum Rhein Main

    ACTIVE_NOT_RECRUITING

    Frankfurt am Main, Hesse, 60596, Germany

  • John Hopkins University

    ACTIVE_NOT_RECRUITING

    Baltimore, Maryland, 21287, United States

  • Medical Research of Arizona

    RECRUITING

    Phoenix, Arizona, 85248, United States

  • Medizinische Hochschule Hannover

    ACTIVE_NOT_RECRUITING

    Hanover, Lower Saxony, 30625, Germany

  • Riverside Medical Group, Belleville

    RECRUITING

    Belleville, New Jersey, 07109, United States

  • Universitaetsklinikum Carl Gustav Carus TU Dresden

    RECRUITING

    Leipzig, Saxony, 01307, Germany

  • Universitaetsklinikum Schleswig Holstein - Campus Luebeck

    RECRUITING

    Hamburg, Schleswig-Holstein, 23538, Germany

  • Washington University

    ACTIVE_NOT_RECRUITING

    St Louis, Missouri, 63141, United States

Conditions

Explore the condition pages connected to this study.